Abstract 3559: A crowd-control approach for castration-resistant prostate cancer therapeutics

Mapping Intimacies ◽

10.1158/1538-7445.am2019-3559 ◽

2019 ◽

Author(s):

Girish C. Shukla

Keyword(s):

Prostate Cancer ◽

Cancer Therapeutics ◽

Castration Resistant Prostate Cancer ◽

Control Approach ◽

Castration Resistant ◽

Download Full-text

Abstract 3559: A crowd-control approach for castration-resistant prostate cancer therapeutics

10.1158/1538-7445.sabcs18-3559 ◽

2019 ◽

Author(s):

Girish C. Shukla

Keyword(s):

Prostate Cancer ◽

Cancer Therapeutics ◽

Castration Resistant Prostate Cancer ◽

Control Approach ◽

Castration Resistant ◽

Download Full-text

Cancer therapeutics-related cardiac dysfunction in a patient treated with abiraterone for castration-resistant prostate cancer

Journal of Medical Ultrasonics ◽

10.1007/s10396-018-0897-7 ◽

2018 ◽

Vol 46 (2) ◽

pp. 239-243 ◽

Author(s):

Toshimitsu Tsugu ◽

Yuji Nagatomo ◽

Yuki Nakajima ◽

Toshimi Kageyama ◽

Yushi Akise ◽

...

Keyword(s):

Prostate Cancer ◽

Cardiac Dysfunction ◽

Cancer Therapeutics ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Neuroendocrine secretory profiles are not associated with treatment response to Lu-177-PSMA-617 radioligand therapy in patients with advanced metastatic castration-resistant prostate cancer

10.1055/s-0040-1708342 ◽

2020 ◽

Author(s):

T Derlin ◽

R Werner ◽

C Henkenberens ◽

TL Ross ◽

FM Bengel

Keyword(s):

Prostate Cancer ◽

Treatment Response ◽

Castration Resistant Prostate Cancer ◽

Radioligand Therapy ◽

Castration Resistant

Download Full-text

Prostate specific membrane antigen targeted radioligand therapy of metastatic castration-resistant prostate cancer using Lu-177 PSMA-617: safety, efficacy and dosimetry in comparison with Lu-177 PSMA I&T

Endocrine Abstracts ◽

10.1530/endoabs.47.oc32 ◽

2016 ◽

Author(s):

Harshad R. Kulkarni ◽

Aviral Singh ◽

Christiane Schuchardt ◽

Karin Niepsch ◽

Richard P. Baum

Keyword(s):

Prostate Cancer ◽

Prostate Specific Membrane Antigen ◽

Castration Resistant Prostate Cancer ◽

Radioligand Therapy ◽

Castration Resistant ◽

Specific Membrane

Download Full-text

New combination therapies for castration-resistant prostate cancer

Oncology Abstracts ◽

10.1530/oncolabs.1.p031 ◽

2019 ◽

Author(s):

Mitchell G Lawrence ◽

Laura H Porter ◽

Daisuke Obinata ◽

Shahneen Sandhu ◽

Luke A Selth ◽

...

Keyword(s):

Prostate Cancer ◽

New Combination ◽

Combination Therapies ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

The role of microbiota in driving castration-resistant prostate cancer

10.26226/morressier.5f69edb69b74b699bf38c5cf ◽

2020 ◽

Author(s):

Arianna Calcinotto

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

FDA approves darolutamide for non-metastatic castration-resistant prostate cancer

Case Medical Research ◽

10.31525/cmr-1904aca ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Case Medical Research ◽

10.31525/ct1-nct03851640 ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Efficacy And Safety ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer

Case Medical Research ◽

10.31525/ct1-nct03874884 ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer

Case Medical Research ◽

10.31525/ct1-nct03972657 ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text